Molecular Mechanisms of Neuropathic Pain

Drug News and Perspectives

Volumn 16, Issue 9, 2003, Pages 605-613

  Ueda, Hiroshi ^a   Rashid, M Harunor ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE; NEUROKININ 1 RECEPTOR ANTAGONIST; ANALGESIC AGENT;

ANALGESIA; ANALGESIC ACTIVITY; DISEASE SEVERITY; DRUG EFFECT; DRUG RECEPTOR BINDING; DRUG TARGETING; INFLAMMATION; MEDICAL CARE; MOLECULAR BIOLOGY; NEUROPATHIC PAIN; NEUROPATHOLOGY; NONHUMAN; REVIEW; SYMPTOM; TREATMENT PLANNING; ANIMAL; DISEASE MODEL; HUMAN; INTRACTABLE PAIN; METABOLISM; PAIN; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY;

ANALGESICS; ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; PAIN; PAIN, INTRACTABLE; PERIPHERAL NERVOUS SYSTEM DISEASES;

EID: 0347088939     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2003.16.9.829343     Document Type: Review

References (88)

1. Woolf, C.J. and Salter, M.W. Neuronal plasticity: Increasing the gain in pain. Science 2000, 288: 1765-7.
2. Woolf, C.J. and Mannion, R.J. Neuropathic pain: Aetiology, symptoms, mechanisms and management. Lancet 1999, 353: 1959-64.
3. Arner, S. and Meyerson, B.A. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain 1988, 33: 11-23.
4. Sindrup, S.H. and Jensen, T.H. Efficacy of pharmacological treatments of neuropathic pain: An update and effect related to mechanism of drug action. Pain 1999, 83: 389-400.
5. McQuay, H.J., Tramer, M., Nye, B.A., Carroll, D., Wiffen, P.J. and Moore, R.A. A systematic review of antidepressants in neuropathic pain. Pain 1996, 68: 217-27.
6. Przewlocki, R. and Przewlocka, B. Opioids in chronic pain. Eur J Pharmacol 2001, 429: 79-91.
7. Bennett, G.J. and Xie, Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1988, 33: 87-107.
8. Seltzer, Z., Dubner, R. and Shir, Y. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain 1990, 43: 205-18.
9. Malmberg, A.B. and Basbaum, A.I. Partial sciatic nerve injury in the mouse as a model of neuropathic pain: Behavioral and neuroanatomical correlates. Pain 1998, 76: 215-22.
10. Kim, S.H. and Chung, J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992, 50: 355-63.
11. Wall, P.D., Devor, M., Inbal, F.R. et al. Autotomy following peripheral nerve lesions: Experimental anaesthesia dolorosa. Pain 1979, 7: 103-11.
12. Kauppila, T. Correlation between autotomy-behavior and current theories of neuropathic pain. Neurosci Biobehav Rev 1998, 23: 111-29.
13. Decosterd, I. and Woolf, C.J. Spared nerve injury: An animal model of persistent peripheral neuropathic pain. Pain 2000, 87: 149-58.
14. Back, S.K., Sung, B., Hong, S.K. and Na, H.S. A mouse model for peripheral neuropathy produced by a partial injury of the nerve supplying the tail. Neurosci Lett 2002, 322: 153-6.
15. Idanpaan-Heikkila, J.J. and Guilbaud, G. Pharmacological studies on a rat model of trigeminal neuropathic pain: Baclofen, but not carbamazepine, morphine or tricyclic anti-depressants, attenuates the allodynia-like behavior. Pain 1999, 79: 281-90.
16. Sima, A.A.F. and Sugimoto, K. Experimental diabetic neuropathy: An update. Diabetologia 1999, 42: 773-88.
17. Courteix, C., Eschalier, A. and Lavarenne, J. Streptozotocin-induced diabetic rats: Behavioural evidence for a model of chronic pain. Pain 1993, 53: 81-8.
18. Kamei, J., Ohhashi, Y., Aoki, T. and Kasuya, Y. Streptozotocin-induced diabetes in mice reduces the nociceptive threshold, as recognized after application of naxious mechanical stimuli but not of thermal stimuli. Pharmacol Biochem Behav 1991, 39: 541-4.
19. Rashid, M.H. and Ueda, H. Nonopioid and neuropathy-specific analgesic action of the nootropic drug nefiracetam in mice. J Pharmacol Exp Ther 2002, 303: 226-31.
20. Aley, K.O., Reichling, D.B. and Levine, J.D. Vincristine hyperalgesia in the rat: A model of painful vincristine neuropathy in humans. Neuroscience 1996, 73: 259-65.
21. Takasaki, I., Andoh, T., Shiraki, K. and Kuraishi, Y. Allodynia and hyperalgesia induced by herpes simplex virus type I infection in mice. Pain 2000, 86: 95-101.
22. Ueda, H. and Inoue, M. Animal models and peripheral nociception tests for the study of neuropathic pain. Nippon Yakurigaku Zasshi 2001, 118: 89-95.
23. Bridges, D., Thompson, S.W.N. and Rice, A.S.C. Mechanisms of neuropathic pain. Br J Anaesth 2001, 87: 12-26.
24. Liu, X., Chung, K. and Chung J.M. Ectopic discharges and adrenergic sensitivity of sensory neurons after spinal nerve injury. Brain Res 1999, 849: 244-7.
25. Dickenson, A.H., Matthews, E.A. and Suzuki, R. Neurobiology of neuropathic pain: Mode of action of anticonvulsants. Eur J Pain 2002, 6(Suppl A): 51-60.
26. Devor, M., Schonfeld, D., Seltzer, Z. and Wall, P.D. Two modes of cutaneous reinnervation following peripheral nerve injury. J Comp Neurol 1979, 185: 211-20.
27. McLachlan, E.M., Janig, W., Devor, M. and Michaelis, M. Peripheral nerve injury triggers noradrenergic sprouting within dorsal root ganglia. Nature 1993, 363: 543-6.
28. Michaelis, M., Vogel, C., Blenk, K.-H., Arnarson, A. and Jaing, W. Inflammatory mediators sensitize acutely axotomized nerve fibers to mechanical stimulation in the rat. J Neurosci 1998, 18: 7581-7.
29. + channels. J Neurophysiol 1994, 72: 349-59.
30. Hokfelt, T., Broberger, C., Xu, Z.Q., Sergeyev, V., Ubink, R. and Diez, M. Neuropeptides-An overview. Neuropharmacology 2000, 39: 1337-56.
31. + channel accumulation on axolemma of afferent endings in nerve end neuromas in Apteronotus. Neurosci Lett 1989, 102: 149-54.
32. Waxman, S.G., Dib-Hajj, S., Cummins, T.R. and Black, J.A. Sodium channels and pain. Proc Natl Acad Sci USA 1999, 96: 7635-9.
33. Dib-Hajj, S., Black, J.A., Felts, P. and Waxman, S.G. Down-regulation of transcripts for Na channel alpha-SNS in spinal sensory neurons following axotomy. Proc Natl Acad Sci USA 1996, 93: 14950-4.
34. Porreca, F., Lai, J., Bian, D. et al. A comparison of the potential role of the tetrodotoxin-insensitive sodium channels, PN3/SNS and NaN/SNS2, in rat models of chronic pain. Proc Natl Acad Sci USA 1999, 96: 7640-4.
35. Gold, M.S., Weinreich, D., Kim, C.-S. et al. Redistribution of Nav1.8 in uninjured axons enables neuropathic pain. J Neurosci 2003, 23: 158-66.
36. Waxman, S.G., Kocsis, J.D. and Black, J.A. Type III sodium channel mRNA is expressed in embryonic, but not adult spinal sensory neurons, and is reexpressed following axotomy. J Neurophysiol 1994, 72: 466-70.
37. Abe, M., Kurihara, T., Han, W., Shinomiya, K. and Tanabe, T. Changes in expression of voltage-dependent ion channel subunits in dorsal root ganglia of rats with radicular injury and pain. Spine 2002, 27: 1517-24.
38. Caterina, M.J. and Julius, D. The vanilloid receptor: A molecular gateway to the pain pathway. Annu Rev Neurosci 2001, 24: 487-517.
39. Hudson, L.J., Bevan, S., Wotherspoon, G., Gentry, C., Fox, A. and Winter, J. VRI protein expression increases in undamaged DRG neurons after partial nerve injury. Eur J Neurosci 2001, 13: 2105-14.
40. Rashid, M.H., Inoue, M., Kondo, S., Kawashima, T., Bakoshi, S. and Ueda, H. Novel expression of vanilloid receptor 1 (VRI) on capsaicin-insensitive fibers accounts for the analgesic effect of capsaicin cream in neuropathic pain. J Pharmacol Exp Ther 2003, 304: 940-8.
41. Di Marzo, V., Blumberg, P.M. and Szallasi, A. Endovanilloid signaling in pain. Curr Opin Neurobiol 2002, 12: 372-9.
42. Chen, C.C., Akopian, A.N., Sivilotti, L., Colquhoun, D., Burnstock, G. and Wood, J.N. A P2X purinoceptor expressed by a subset of sensory neurons. Nature 1995, 377: 428-31.
43. 3 receptor subunit in rat sensory neurons reveals a significant role in chronic neuropathic and inflammatory, pain. J Neurosci 2002, 22: 8139-47.
44. Saegusa, H., Kurihara, T., Zong, S. et al. Suppression of inflammatory and neuropathic pain symptoms in mice lacking the N-type Ca2+ channel. EMBO J 2001, 20: 2349-56.
45. Xiao, W.H. and Bennett, G.J. Synthetic omega-conopeptides applied to the site of nerve injury suppress neuropathic pain in rats. J Pharmacol Exp Ther 1995, 274: 666-72.
46. Chaplan, S.R., Guo, H.Q., Lee, D.H. et al. Neuronal hyperpolarization-activated pacemaker channels drive neuropathic pain. J Neurosci 2003, 23: 1169-78.
47. Hokfelt, T., Zhang, X. and Wiesenfeld-Hallin, Z. Messenger plasticio, in primary sensory neurons following axotomy and its functional implications. Trends Neurosci 1994, 17: 2230.
48. Wiesenfeld-Hallin, Z. and Xu, X.J. Neuropeptides in neuropathic and inflammatory pain with special emphasis on cholecystokinin and galanin. Eur J Pharmacol 2001, 429: 49-59.
49. Xiao, H.-S., Huang, Q.-H., Zhang, F.-X. et al. Identification of gene expression profile of dorsal root ganglion in the rat peripheral axotomy model of neuropathic pain. Proc Natl Acad Sci USA 2002, 99: 8360-5.
50. Ossipov, M.H., Zhang, E.T., Carvajal, C. et al. Selective mediation of nerve injury-induced tactile hypersensitivity by neuropeptide Y. J Neurosci 2002, 22: 9858-67.
51. Kerr, B.J., Thompson, S.W., Wynick, D. and McMahon, S.B. Endogenous galanin is required for the full expression of central sensitization following peripheral nerve injury. Neuroreport 2001, 12: 3331-4.
52. Jongsma, H., Danielsen, N., Sundler, F. and Kanje, M. Alteration of PACAP distribution and PACAP receptor binding in the rat sensory nervous system following sciatic nerve transection. Brain Res 2000, 853: 186-96.
53. Colton, A.M. and Fallat, L.M. Complex regional pain syndrome. J Foot Ankle Surg 1996, 35: 284-96.
54. Lee, D.H., Liu, X., Kim, H.T., Chung, K. and Chung, J.M. Receptor subtype mediating the adrenergic sensitivity of pain behavior and ectopic discharges in neuropathic Lewis rats. J Neurophysiol 1999, 81: 2226-33.
55. Jones, M.G., Munson, J.B. and Thompson, S.W. A role for nerve growth factor in sympathetic sprouting in rat dorsal root ganglia. Pain 1999, 79: 21-9.
56. Ro, L.S., Chen, S.T., Tang, L.M. and Chang, H.S. Local application of anti-NGF blocks the collateral sprouting in rats following chronic constriction injury of the sciatic nerve. Neurosci Lett 1996, 218: 87-90.
57. Levy, D. and Zochodne, D.W. Increased mRNA expression of the B1 and B2 bradykinin receptors and antinociceptive effects of their antagonists in an animal model of neuropathic pain. Pain 2000, 86: 265-71.
58. Syriatowicz, J.P., Hu, D., Walker, J.S. and Tracey, D.J. Hyperalgesia due to nerve injury: Role of prostaglandins. Neuroscience 1999, 94: 587-94.
59. England, S., Bevan, S. and Docherty, R.J. PGE2 modulates the tetrodotoxin-resistant sodium current in neonatal rat dorsal root ganglion neurons via the cyclic AMP-protein kinase A cascade. J Physiol 1996, 495: 429-40.
60. Premkumar, L.S. and Ahem, G.P. Induction of vanilloid receptor channel activity by protein kinase C. Nature 2000, 408: 985-90.
61. De Petrocellis, L., Harrison, S., Bisogno, T. et al. The vanilloid receptor (VRI)-mediated effects of anandamide are potently enhanced by the cAMP-dependent protein kinase. J Neurochem 2001, 77: 1660-3.
62. Sommer, C., Schmidt, C. and George, A. Hyperalgesia in experimental neuropathy is dependent on the TNF receptor 1. Exp Neurol 1998, 151: 138-42.
63. Sommer, C., Petrausch, S., Lindenlaub, T. and Toyka, K.V. Neutralizing antibodies to interleukin 1-receptor reduce pain-associated behavior in mice with experimental neuropathy. Neurosci Lett 1999, 270: 25-8.
64. Doubell, T.P., Mannion, R.J. and Woolf, C.J. The dorsal horn: State-dependent sensory processing, plasticity and the generation of pain. In: Textbook of Pain. Fourth Edition. P.D. Wall and R. Melzack (Eds.). Churchill Livingstone, London 1999, 165-81.
65. Woolf, C.J., Shortland, P. and Coggeshall, R.E. Peripheral nerve injury triggers central sprouting of myelinated afferents. Nature 1992, 355: 75-8.
66. Woolf, C.J. The pathophysiology of peripheral neuropathic pain-Abnormal peripheral input and abnormal central processing. Acta Neurochir Suppl 1993, 58: 125-30.
67. Dubner, R. Neuronal plasticity in the spinal cord medullary dorsal horn: A possible role in central pain mechanisms. In: Pain and Central Nervous System Disease. K.L. Casey (Ed.). Raven Press, New York 1991, 143-55.
68. Castro-Lopes, J.M., Coimbra, A., Grant, G. and Arvidsson, J. Ultrastructural changes of the central scalloped (C1) primary afferent endings of synaptic glomeruli in the substantia gelatinosa ronaldi of the rat after peripheral neurotomy. J Neurocytol 1990, 19: 329-37.
69. Sandkuhler, J. and Liu, X.-G. Induction of long-term potentiation at spinal synapses by noxious stimulation or nerve injury. Eur J Neurosci 1998, 2476-80.
70. Zimmermann, M. Pathobiology of neuropathic pain. Eur J Pharmacol 2001, 429: 23-37.
71. Hua, X.Y., Chen, P. and Yaksh, T.L. Inhibition of spinal protein kinase C reduces nerve injury-induced tactile allodynia in neuropathic rats. Neurosci Lett 1999, 276: 99-102.
72. Rashid, M.H. and Ueda, H. Neuropathy-specific analgesic action of intrathecal nicotinic agonists and its spinal GABA-mediated mechanism. Brain Res 2002, 953: 53-62.
73. Moore, K.A., Kohno, T., Karchewski, L.A., Scholz, J., Baba, H. and Woolf, C.J. Partial peripheral nerve injury promotes a selective loss of GABAergic inhibition in the superficial dorsal horn of the spinal cord. J Neurosci 2002, 22: 6724-31.
74. Zhang, X., Bao, L., Shi, T.J., Ju, G., Elde, R. and Hokfelt, T. Down-regulation of mu-opioid receptors in rat and monkey dorsal root ganglion neurons and spinal cord after peripheral axotomy. Neuroscience 1998, 82: 223-40.
75. Vanderah, T.W., Gardell, L.R., Burgess, S.E. et al. Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance. Neuroscience 2000, 20: 7074-9.
76. Zhang, X., de Araujo Lucas, G., Elde, R., Wiesenfeld-Hallin, Z. and Hokfelt, T. Effect of morphine on cholecystokinin and mu-opioid receptor-like immunoreactivities in rat spinal dorsal horn neurons after peripheral axotomy and inflammation. Neuroscience 2000, 95: 197-207.
77. Urban, M.O. and Gebhart, G.F. Supraspinal contributions to hyperalgesia. Proc Natl Acad Sci USA 1999, 96: 7687-92.
78. Pertovaara, A., Wei, H. and Hamalainen, M.M. Lidocaine in the rostroventromedial medulla and the periaqueductal gray attenuates allodynia in neuropathic rats. Neurosci Lett 1996, 218: 127-30.
79. Bian, D., Ossipov, M.H., Zhong, C., Malan, T.P., Jr. and Porreca, F. Tactile allodynia, but not thermal hyperalgesia, of the hindlimbs is blocked by spinal transection in rats with nerve injury. Neurosci Lett 1998, 241: 79-82.
80. Pertovaara, A., Kontinen, V.K. and Kalso, E.A. Chronic spinal nerve ligation induces changes in response characteristics of nociceptive spinal dorsal horn neurons and in their descending regulation originating in the periaqueductal gray in the rat. Exp Neurol 1997, 147: 428-36.
81. Vanderah, T.W., Suenaga, N.M., Ossipov, M.H., Malan, T.P., Jr., Lai, J. and Porreca, F. Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance. J Neurosci 2001, 21: 279-86.
82. Le Bars, D., Gozariu, M. and Cadden, S.W. Animal models of nociception. Pharmacol Rev 2001, 53: 597-652.
83. Ueda, H. In vivo molecular signal transduction of peripheral mechanisms of pain. Jpn J Pharmacol 1999, 79: 263-8.
84. Inoue, M., Rashid, M.H., Kawashima, T., Matsumoto, M., Maeda, T., Kishioka, S. and Ueda, H. The algogenic-induced nociceptive flexion test in mice: Studies on sensitivity of the test and stress on animals. Brain Res Bull, 60: 275-81.
85. Inoue, M., Kobayashi, M., Kozaki, S., Zimmer, A. and Ueda, H. Nociceptin/ orphanin FQ-induced nociceptive responses through substance P release from peripheral nerve ending in mice. Proc Natl Acad Sci USA 1998, 95: 10949-53.
86. Ueda, H. and Inoue, M. In vivo signal transduction of nociceptive responses by kyotorphin (tyrosine-arginine) through Galphai-and inositol trisphosphate-mediated Ca2+ influx. Mol Pharmacol 2000, 57: 108-15.
87. Inoue, M., Kawashima, T., Takeshima, H., Calo, G., Inoue, A., Nakata, Y., and Ueda, H. In vivo pain-inhibitory tole of nociceptin/ orphanin FQ in spinal cord. J Pharmacol Exp Ther, 305: 495-501.
88. Ueda, H., Matsunaga, S., Inoue, M., Yamamoto, Y. and Hazato, T. Complete inhibition of purinoceptor agonist-induced nociception by spinorphin, but not by morphine. Peptides 2000, 21: 1215-21.